Medistim ASA (0OCD.L)

181.02 -37.00 (-16.97%) At close: 05:44PM BST

Medistim ASA

Økernveien 94
Oslo 0579
Norway
47 23 05 96 60
https://medistim.com

Sector(s): 
Industry: 
Full-time employees: 150

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Kari Eian Krogstad	CEO & President	4.41M	N/A	1964
Mr. Thomas Jakobsen	Chief Financial Officer	2.59M	N/A	1969
Mr. Helge Borslid	Vice President of Operations & Manufacturing	1.67M	N/A	N/A
Ms. Hæge Johanne Krogh Wetterhus	Vice President of Marketing	1.84M	N/A	1964
Mr. Hakon Grothe	Chief Innovation Officer	1.77M	N/A	N/A
Mr. Ole Arne Eiksund	Chief Business Development Officer	1.68M	N/A	1967

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.

Description

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. It operates through Sale of Own Products; and Sale of 3. Party Products segments. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; MiraQ Ultimate, which uses flow measurement and ultrasound imaging probes to provide a complete assessment; and imaging probes for intraoperative use. It also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical devices. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Corporate governance

Medistim ASA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.